-
A Proof-of-Concept Study to Assess the Efficacy Safety and Tolerability of itepekimab (anti-IL-33 mAb) in Participants with Non-Cystic Fibrosis Bronchiectasis
This study aims to evaluate the safety, efficacy, and tolerability of itepekimab in patients with bronchiectasis, in addition to their current treatment regimen, which may ...Phase
Interventional
-
Implementing an effective Diabetes intervEntion Among Low-income immigrants (IDEAL Study)
Dr. Lu Hu and her research team at NYU Langone Health are conducting a study to evaluate the effectiveness of a culturally and linguistically tailored ...Phase
Interventional
-
LINK-IT: Leveraging vIdeos and commuNity health worKers to address socIal determinants of health in Immigrants
The research team led by Dr. Lu Hu at NYU Langone Health is conducting a study to understand whether a culturally and linguistically tailored diabetes ...Phase
Interventional
-
A Phase 2b Randomized Double-blind Placebo-controlled Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of GSBR-1290 in Participants Living with Obesity (Body Mass Index = 30 kg/m2) or Overweight (Body Mass Index = 27 kg/m2) with at Least One Weight-related Comorbidity
This study is evaluating a drug called GSBR-1290, which is being developed by Gasherbrum Bio, Inc. (“the Sponsor”), a biopharmaceutical company with headquarters in the ...Phase
Interventional
